Small-animal PET imaging of amyloid-beta plaques with [11C]PiB and its multi-modal validation in an APP/PS1 mouse model of Alzheimer's disease.
In vivo imaging and quantification of amyloid-β plaque (Aβ) burden in small-animal models of Alzheimer's disease (AD) is a valuable tool for translational research such as developing specific imaging markers and monitoring new therapy approaches. Methodological constraints such as image resolut...
Guardado en:
| Autores principales: | , , , , , , , , , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Public Library of Science (PLoS)
2012
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/de3fe45cefe545f0bc8727bd2b9c0fdd |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:de3fe45cefe545f0bc8727bd2b9c0fdd |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:de3fe45cefe545f0bc8727bd2b9c0fdd2021-11-18T07:25:40ZSmall-animal PET imaging of amyloid-beta plaques with [11C]PiB and its multi-modal validation in an APP/PS1 mouse model of Alzheimer's disease.1932-620310.1371/journal.pone.0031310https://doaj.org/article/de3fe45cefe545f0bc8727bd2b9c0fdd2012-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22427802/pdf/?tool=EBIhttps://doaj.org/toc/1932-6203In vivo imaging and quantification of amyloid-β plaque (Aβ) burden in small-animal models of Alzheimer's disease (AD) is a valuable tool for translational research such as developing specific imaging markers and monitoring new therapy approaches. Methodological constraints such as image resolution of positron emission tomography (PET) and lack of suitable AD models have limited the feasibility of PET in mice. In this study, we evaluated a feasible protocol for PET imaging of Aβ in mouse brain with [(11)C]PiB and specific activities commonly used in human studies. In vivo mouse brain MRI for anatomical reference was acquired with a clinical 1.5 T system. A recently characterized APP/PS1 mouse was employed to measure Aβ at different disease stages in homozygous and hemizygous animals. We performed multi-modal cross-validations for the PET results with ex vivo and in vitro methodologies, including regional brain biodistribution, multi-label digital autoradiography, protein quantification with ELISA, fluorescence microscopy, semi-automated histological quantification and radioligand binding assays. Specific [(11)C]PiB uptake in individual brain regions with Aβ deposition was demonstrated and validated in all animals of the study cohort including homozygous AD animals as young as nine months. Corresponding to the extent of Aβ pathology, old homozygous AD animals (21 months) showed the highest uptake followed by old hemizygous (23 months) and young homozygous mice (9 months). In all AD age groups the cerebellum was shown to be suitable as an intracerebral reference region. PET results were cross-validated and consistent with all applied ex vivo and in vitro methodologies. The results confirm that the experimental setup for non-invasive [(11)C]PiB imaging of Aβ in the APP/PS1 mice provides a feasible, reproducible and robust protocol for small-animal Aβ imaging. It allows longitudinal imaging studies with follow-up periods of approximately one and a half years and provides a foundation for translational Alzheimer neuroimaging in transgenic mice.André ManookBehrooz H YousefiAntje WilluweitStefan PlatzerSybille RederAndreas VossMarc HuismanMarkus SettlesFrauke NeffJoachim VeldenMichael SchoorHeinz von der KammerHans-Jürgen WesterMarkus SchwaigerGjermund HenriksenAlexander DrzezgaPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 7, Iss 3, p e31310 (2012) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
Medicine R Science Q |
| spellingShingle |
Medicine R Science Q André Manook Behrooz H Yousefi Antje Willuweit Stefan Platzer Sybille Reder Andreas Voss Marc Huisman Markus Settles Frauke Neff Joachim Velden Michael Schoor Heinz von der Kammer Hans-Jürgen Wester Markus Schwaiger Gjermund Henriksen Alexander Drzezga Small-animal PET imaging of amyloid-beta plaques with [11C]PiB and its multi-modal validation in an APP/PS1 mouse model of Alzheimer's disease. |
| description |
In vivo imaging and quantification of amyloid-β plaque (Aβ) burden in small-animal models of Alzheimer's disease (AD) is a valuable tool for translational research such as developing specific imaging markers and monitoring new therapy approaches. Methodological constraints such as image resolution of positron emission tomography (PET) and lack of suitable AD models have limited the feasibility of PET in mice. In this study, we evaluated a feasible protocol for PET imaging of Aβ in mouse brain with [(11)C]PiB and specific activities commonly used in human studies. In vivo mouse brain MRI for anatomical reference was acquired with a clinical 1.5 T system. A recently characterized APP/PS1 mouse was employed to measure Aβ at different disease stages in homozygous and hemizygous animals. We performed multi-modal cross-validations for the PET results with ex vivo and in vitro methodologies, including regional brain biodistribution, multi-label digital autoradiography, protein quantification with ELISA, fluorescence microscopy, semi-automated histological quantification and radioligand binding assays. Specific [(11)C]PiB uptake in individual brain regions with Aβ deposition was demonstrated and validated in all animals of the study cohort including homozygous AD animals as young as nine months. Corresponding to the extent of Aβ pathology, old homozygous AD animals (21 months) showed the highest uptake followed by old hemizygous (23 months) and young homozygous mice (9 months). In all AD age groups the cerebellum was shown to be suitable as an intracerebral reference region. PET results were cross-validated and consistent with all applied ex vivo and in vitro methodologies. The results confirm that the experimental setup for non-invasive [(11)C]PiB imaging of Aβ in the APP/PS1 mice provides a feasible, reproducible and robust protocol for small-animal Aβ imaging. It allows longitudinal imaging studies with follow-up periods of approximately one and a half years and provides a foundation for translational Alzheimer neuroimaging in transgenic mice. |
| format |
article |
| author |
André Manook Behrooz H Yousefi Antje Willuweit Stefan Platzer Sybille Reder Andreas Voss Marc Huisman Markus Settles Frauke Neff Joachim Velden Michael Schoor Heinz von der Kammer Hans-Jürgen Wester Markus Schwaiger Gjermund Henriksen Alexander Drzezga |
| author_facet |
André Manook Behrooz H Yousefi Antje Willuweit Stefan Platzer Sybille Reder Andreas Voss Marc Huisman Markus Settles Frauke Neff Joachim Velden Michael Schoor Heinz von der Kammer Hans-Jürgen Wester Markus Schwaiger Gjermund Henriksen Alexander Drzezga |
| author_sort |
André Manook |
| title |
Small-animal PET imaging of amyloid-beta plaques with [11C]PiB and its multi-modal validation in an APP/PS1 mouse model of Alzheimer's disease. |
| title_short |
Small-animal PET imaging of amyloid-beta plaques with [11C]PiB and its multi-modal validation in an APP/PS1 mouse model of Alzheimer's disease. |
| title_full |
Small-animal PET imaging of amyloid-beta plaques with [11C]PiB and its multi-modal validation in an APP/PS1 mouse model of Alzheimer's disease. |
| title_fullStr |
Small-animal PET imaging of amyloid-beta plaques with [11C]PiB and its multi-modal validation in an APP/PS1 mouse model of Alzheimer's disease. |
| title_full_unstemmed |
Small-animal PET imaging of amyloid-beta plaques with [11C]PiB and its multi-modal validation in an APP/PS1 mouse model of Alzheimer's disease. |
| title_sort |
small-animal pet imaging of amyloid-beta plaques with [11c]pib and its multi-modal validation in an app/ps1 mouse model of alzheimer's disease. |
| publisher |
Public Library of Science (PLoS) |
| publishDate |
2012 |
| url |
https://doaj.org/article/de3fe45cefe545f0bc8727bd2b9c0fdd |
| work_keys_str_mv |
AT andremanook smallanimalpetimagingofamyloidbetaplaqueswith11cpibanditsmultimodalvalidationinanappps1mousemodelofalzheimersdisease AT behroozhyousefi smallanimalpetimagingofamyloidbetaplaqueswith11cpibanditsmultimodalvalidationinanappps1mousemodelofalzheimersdisease AT antjewilluweit smallanimalpetimagingofamyloidbetaplaqueswith11cpibanditsmultimodalvalidationinanappps1mousemodelofalzheimersdisease AT stefanplatzer smallanimalpetimagingofamyloidbetaplaqueswith11cpibanditsmultimodalvalidationinanappps1mousemodelofalzheimersdisease AT sybillereder smallanimalpetimagingofamyloidbetaplaqueswith11cpibanditsmultimodalvalidationinanappps1mousemodelofalzheimersdisease AT andreasvoss smallanimalpetimagingofamyloidbetaplaqueswith11cpibanditsmultimodalvalidationinanappps1mousemodelofalzheimersdisease AT marchuisman smallanimalpetimagingofamyloidbetaplaqueswith11cpibanditsmultimodalvalidationinanappps1mousemodelofalzheimersdisease AT markussettles smallanimalpetimagingofamyloidbetaplaqueswith11cpibanditsmultimodalvalidationinanappps1mousemodelofalzheimersdisease AT fraukeneff smallanimalpetimagingofamyloidbetaplaqueswith11cpibanditsmultimodalvalidationinanappps1mousemodelofalzheimersdisease AT joachimvelden smallanimalpetimagingofamyloidbetaplaqueswith11cpibanditsmultimodalvalidationinanappps1mousemodelofalzheimersdisease AT michaelschoor smallanimalpetimagingofamyloidbetaplaqueswith11cpibanditsmultimodalvalidationinanappps1mousemodelofalzheimersdisease AT heinzvonderkammer smallanimalpetimagingofamyloidbetaplaqueswith11cpibanditsmultimodalvalidationinanappps1mousemodelofalzheimersdisease AT hansjurgenwester smallanimalpetimagingofamyloidbetaplaqueswith11cpibanditsmultimodalvalidationinanappps1mousemodelofalzheimersdisease AT markusschwaiger smallanimalpetimagingofamyloidbetaplaqueswith11cpibanditsmultimodalvalidationinanappps1mousemodelofalzheimersdisease AT gjermundhenriksen smallanimalpetimagingofamyloidbetaplaqueswith11cpibanditsmultimodalvalidationinanappps1mousemodelofalzheimersdisease AT alexanderdrzezga smallanimalpetimagingofamyloidbetaplaqueswith11cpibanditsmultimodalvalidationinanappps1mousemodelofalzheimersdisease |
| _version_ |
1718423503307276288 |